nifedipine and sc-46275

nifedipine has been researched along with sc-46275 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, KM; Hidaka, H; Hung, GH; Jones, RL; Lam, FF; Sasaki, Y; Suzuki, M	1

Other Studies

1 other study(ies) available for nifedipine and sc-46275

Article	Year
Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery. Prostaglandins, leukotrienes, and essential fatty acids, 2006, Volume: 74, Issue:6 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Dinoprostone; Drug Interactions; Drug Synergism; Femoral Artery; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Nifedipine; Phenylephrine; Potassium; Prostaglandins F, Synthetic; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP3 Subtype; rho-Associated Kinases; Sensitivity and Specificity; Sulfonamides; Vasoconstrictor Agents	2006

Article

Year

Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery.

Prostaglandins, leukotrienes, and essential fatty acids, 2006, Volume: 74, Issue:6

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Dinoprostone; Drug Interactions; Drug Synergism; Femoral Artery; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Nifedipine; Phenylephrine; Potassium; Prostaglandins F, Synthetic; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP3 Subtype; rho-Associated Kinases; Sensitivity and Specificity; Sulfonamides; Vasoconstrictor Agents

2006